tci Medicare Compliance & Reimbursement - 2003 Issue 38

Pharmaceuticals: GENERIC COMPANIES NEXT TARGET IN DRUG PRICING WAR

"Marketing the spread"  alleged in sweeping new lawsuit  The campaign by state fraud fighters against pharmaceutical companies that report inaccurate pricing information shows no signs of abating. And manufacturers of generic drugs may be the next big target. In a lawsuit filed Sept. 25, Massachusetts Attorney General Tom Reilly accused 13 generic drugmakers of engaging in improper pricing and marketing schemes that cost the Bay State's Medicaid program more than $50 million. The two key elements of the suit should be familiar to those who've been watching the litigation launched in other states against brand-name manufacturers. First, Reilly's office...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.